Carret Asset Management, LLC Amgen Inc Transaction History

Carret Asset Management, LLC

$898 Million
Q3 2024

A detailed history of Carret Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Carret Asset Management, LLC holds 4,179 shares of AMGN stock, worth $1.17 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,179

Previous 4,212 0.78%

Holding current value

$1.17 Million

Previous $1.32 Million 2.28%

% of portfolio

0.15%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $10,209 - $11,133	-33 Reduced 0.78%	4,179 $1.35 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $137,943 - $167,637	-525 Reduced 11.08%	4,212 $1.32 Million
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $282,313 - $340,788	-1,050 Reduced 18.14%	4,737 $1.35 Million
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $10,228 - $11,538	-40 Reduced 0.69%	5,787 $1.67 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $20,784 - $24,576	-97 Reduced 1.64%	5,827 $1.29 Million
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $154,824 - $196,722	-676 Reduced 10.24%	5,924 $1.56 Million
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $3,460 - $3,851	-15 Reduced 0.23%	6,600 $1.61 Million
Q4 2021 Jan 10, 2022	BUY	$198.88 - $227.6 $188,936 - $216,220	950 Added 16.77%	6,615 $1.49 Million
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $2,759 - $3,233	13 Added 0.23%	5,665 $1.21 Million
Q1 2021 Jul 14, 2021	SELL	$221.91 - $258.6 $32,842 - $38,272	-148 Reduced 2.55%	5,652 $1.41 Million
Q4 2020 Mar 16, 2021	BUY	$216.38 - $257.67 $10,819 - $12,883	50 Added 0.87%	5,800 $1.33 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $4,945 - $6,068	25 Added 0.44%	5,750 $1.36 Million
Q1 2020 May 18, 2020	BUY	$182.24 - $241.7 $27,336 - $36,255	150 Added 2.69%	5,725 $1.16 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $9,460 - $12,160	-50 Reduced 0.89%	5,575 $1.34 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $34,822 - $41,724	-200 Reduced 3.43%	5,625 $1.09 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $16,503 - $19,345	99 Added 1.73%	5,825 $1.07 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $179,061 - $201,841	990 Added 20.9%	5,726 $1.09 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 2.07%	4,736 $922,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $22,605 - $25,484	-122 Reduced 2.46%	4,836 $1 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $42,526 - $49,698	-251 Reduced 4.82%	4,958 $845,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $14,853 - $16,595	88 Added 1.72%	5,209 $906,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $75,280 - $85,950	-450 Reduced 8.08%	5,121 $955,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,571	5,571 $959,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Account

Carret Asset Management, LLC Amgen Inc Transaction History